ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.

Saved in:
Bibliographic Details
Title: ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.
Authors: Raza M; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Rajan AR; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Kennedy BB; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Reznicek TE; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Oruji F; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Mirza S; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA.; Department of Chemistry, College of Science, UAEU University, Al Ain, Abu Dhabi, United Arab Emirates., Rowley MJ; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA., Stephan C; Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kristiansen G; Institute for Pathology, University Hospital Carl-Gustav-Carus, University of Technology, Dresden, Dresden, Germany., Datta K; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA.; Department of Biochemistry and Molecular Biology, Massy Cancer Center, Virginia Commonwealth University, Richmond, VA, USA., Mohapatra BC; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. bmohapat@unmc.edu., Band H; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. hband@unmc.edu.; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. hband@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. hband@unmc.edu., Band V; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. vband@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA. vband@unmc.edu.
Source: Oncogene [Oncogene] 2025 Nov; Vol. 44 (42), pp. 4058-4074. Date of Electronic Publication: 2025 Sep 04.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first